Project Grant 20236701539651

Award Date 5/1/23
Completion Date 4/30/26
Dollars Obligated $530K
Federal Grant Program
10.310
Assistance Type
Project Grant
Place of Performance
Stoneville, MS 38776, USA
Similar Awards
The U.S. Department of Agriculture's National Institute of Food and Agriculture (NIFA) awarded a $648,154 Project Grant under the Agriculture and Food Research Initiative (AFRI) competitive grants program to the Agricultural Research Service (ARS), a component of the Government of the United States. The grant supports the development of a multi-strain electron beam (e-beam)-killed vaccine to control Clostridium perfringens-induced necrotic enteritis (NE) and Mycoplasma gallisepticum-induced...
The U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) awarded a $650,000 Project Grant under the Agriculture and Food Research Initiative (CFDA 10.310) to the Division of Agriculture of the University of Arkansas. The award period is from July 1, 2024 to June 30, 2028. The project aims to develop effective interventions to mitigate necrotic enteritis (NE), a prevalent poultry disease causing estimated $6 billion in annual losses worldwide. Key objectives...
The University of Missouri System, under a $650,000 project grant from the USDA National Institute of Food and Agriculture (NIFA) Agriculture and Food Research Initiative (AFRI) program, is developing safe and effective live attenuated swine influenza vaccines using Newcastle disease virus (NDV) as the vector. The project aims to address the challenges with current swine influenza vaccines, which often fail to provide cross-protection against diverse virus strains. The key products and...
The University of Illinois has received a $650,000 Project Grant award from the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) under the Agriculture and Food Research Initiative (AFRI) program. The goal of this 3-year project is to develop a cell-free Marek's disease vaccine that can provide better protection for chickens without the added cost of liquid nitrogen storage required for current cell-associated Marek's disease vaccines. The researchers aim to...
This three-year, $800,000 Project Grant from the United States Department of Agriculture National Institute of Food and Agriculture (USDA NIFA) supports research under the Agriculture and Food Research Initiative (AFRI) competitive grants program (CFDA 10.310). The University of Wisconsin-Madison will develop DNA-based nanoparticle vaccines (nanovaccines) to improve protection against emerging and transboundary poultry infections such as highly pathogenic avian influenza. Researchers will...
The Texas A&M Agrilife Research will conduct research on Marek's disease virus under a $625,000 Project Grant award from the United States Department of Agriculture's National Institute of Food and Agriculture. Funded through the Agriculture and Food Research Initiative (AFRI) competitive grants program (CFDA 10.310), this three-year award will support research aimed at understanding the role of protein kinase in regulating viral growth and the development of Marek's disease, a cancer-like...
The University of Georgia Research Foundation, Inc. (UGA Research Foundation) was awarded a $650,000 Project Grant by the USDA National Institute of Food and Agriculture (NIFA) under the Agriculture and Food Research Initiative (AFRI) program. The grant, awarded on July 1, 2024, will fund research to develop effective mass vaccination strategies using modified live attenuated vaccines (MLVs) against the H9N2 avian influenza virus. The project will analyze the genetic makeup of the H9N2 virus,...
This $649,815 federal Project Grant award from the U.S. Department of Agriculture's National Institute of Food and Agriculture (CFDA 10.310 - Agriculture and Food Research Initiative) is funding research at the University of Minnesota to study and develop new methods for controlling outbreaks of highly pathogenic avian influenza (HPAI) viruses in poultry. The key objectives are to comparatively analyze three strains of the H5N1 HPAI virus, explore their transmission and disease mechanisms in...
This $800,000 Project Grant awarded by the USDA National Institute of Food and Agriculture (NIFA) under the Agriculture and Food Research Initiative (CFDA 10.310) will support Cornell University's development of novel vaccine delivery platforms and serological assays to address the critical challenge of highly pathogenic avian influenza (HPAI) in poultry. Specifically, the university will leverage a condorpox virus vector and self-amplifying RNA technology to rapidly develop and deploy HPAI...
This $299,985 federal Project Grant was awarded by the U.S. Department of Agriculture's National Institute of Food and Agriculture under the Agriculture and Food Research Initiative (CFDA 10.310) program. The grant supports research to identify viral proteins that induce cell-mediated protection against avian influenza in chickens, with the goal of developing broadly protective avian influenza vaccines for poultry. The research will be conducted by the University of Maryland, College Park over a...

The Department of Agriculture's National Institute of Food and Agriculture awarded $530,000 under the Agriculture and Food Research Initiative competitive grants program to develop a trivalent vaccine that protects against Marek's disease, Newcastle disease, and infectious laryngotracheitis in poultry. With a completion date of April 30, 2026, this Project Grant will fund research at the Agricultural Research Service's Southeast Area location in Stoneville, MS to design a single vaccine using Newcastle disease virus as a vector to insert genes encoding antigens of Marek's disease virus and infectious laryngotracheitis virus. Recombinant NDVs expressing antigens of these viruses will be tested for safety, genetic stability, and protective efficacy in chicken challenge models. If successful, a trivalent vaccine capable of protecting against all three diseases will be formulated. This vaccine aims to provide producers benefits over current attenuated live vaccines by being non-recombinogenic, genetically stable at temperatures greater than -80°C, and amenable to in ovo robotic delivery at hatcheries.

Generated 1/16/24, 6:41 AM